NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 25 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $203,040,000 | +60.8% | 18,000,000 | +100.0% | 1.57% | -14.6% |
Q3 2021 | $126,234,000 | -59.6% | 9,000,000 | -50.0% | 1.83% | -9.7% |
Q2 2021 | $312,552,000 | +131.0% | 18,000,000 | +100.0% | 2.03% | +18.6% |
Q1 2021 | $135,324,000 | -18.2% | 9,000,000 | 0.0% | 1.71% | -3.6% |
Q4 2020 | $165,420,000 | +16.6% | 9,000,000 | 0.0% | 1.78% | -14.3% |
Q3 2020 | $141,822,000 | +16.7% | 9,000,000 | 0.0% | 2.07% | +5.2% |
Q2 2020 | $121,500,000 | – | 9,000,000 | – | 1.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 9,000,000 | $165,420,000 | 1.78% |
DeepCurrents Investment Group LLC | 21,930,000 | $39,845,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $21,915,000 | 0.43% |
Polar Asset Management Partners Inc. | 17,500,000 | $31,763,000 | 0.34% |
ZAZOVE ASSOCIATES LLC | 1,320,000 | $2,427,000 | 0.30% |
WOLVERINE ASSET MANAGEMENT LLC | 16,000,000 | $29,227,000 | 0.22% |
PFM Health Sciences, LP | 2,000,000 | $3,666,000 | 0.13% |
Context Capital Management, LLC | 500,000 | $912,000 | 0.12% |
Verition Fund Management LLC | 6,486,000 | $11,825,000 | 0.10% |
LINDEN ADVISORS LP | 3,500,000 | $6,401,000 | 0.05% |